Stay updated on Phase 2 Study of CPI-0610 Combo in Myelofibrosis Clinical Trial
Sign up to get notified when there's something new on the Phase 2 Study of CPI-0610 Combo in Myelofibrosis Clinical Trial page.

Latest updates to the Phase 2 Study of CPI-0610 Combo in Myelofibrosis Clinical Trial page
- CheckyesterdayChange DetectedDifference0.5%
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check15 days agoChange DetectedDifference0.8%
- Check22 days agoChange DetectedThe page has undergone significant content changes, including the removal of detailed study descriptions and inclusion criteria for a clinical trial related to Myelofibrosis and other hematological conditions, while adding new terminology and a revision number.SummaryDifference26%
- Check29 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4, and the date has changed from March 25, 2025, to February 5, 2025.SummaryDifference0.8%
- Check37 days agoChange DetectedThe page has been updated to reflect the latest version as v2.14.3, with the last update date changed to March 25, 2025. The previous version v2.14.2 and its update date of February 5, 2025, have been removed.SummaryDifference0.9%
Stay in the know with updates to Phase 2 Study of CPI-0610 Combo in Myelofibrosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Phase 2 Study of CPI-0610 Combo in Myelofibrosis Clinical Trial page.